Liquidity Agreement and Total Voting Rights
01/11/2022
RNS
CORRECTION: UK CTDA approval of Winterplex 3G
27/10/2022
UK Approval of genesig® SARS-CoV-2 Winterplex® 3G
26/10/2022
03/10/2022
Half year 2022 results
29/09/2022
Notice of Results and Investor Presentation
15/09/2022
01/09/2022
Launch of first fully lyophilised PROmate® assays
04/08/2022
01/08/2022
Launch of research-use-only adenovirus F41 assay
28/07/2022
Results of AGM
20/07/2022
Director/PDMR Shareholding
15/07/2022
Approval of exsig™ COVID-19 Direct test in the UK
07/07/2022
Trading update and progress against strategy
Holdings in Company
05/07/2022
01/07/2022
Launch of monkeypox assay
28/06/2022
Notice of rescheduled AGM
21/06/2022
DHSC dispute update
16/06/2022
For Investor Relations Support for the Novacyt Group, please click the button below to contact our team.
